News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
391,800 Results
Type
Article (26815)
Company Profile (119)
Press Release (364866)
Section
Business (102093)
Career Advice (533)
Deals (18007)
Drug Delivery (79)
Drug Development (38715)
Employer Resources (79)
FDA (10696)
Job Trends (9983)
News (175423)
Policy (20634)
Tag
Academia (2102)
Alliances (28421)
Alzheimer's disease (822)
Approvals (10702)
Artificial intelligence (115)
Bankruptcy (144)
Best Places to Work (8955)
Biotechnology (64)
Breast cancer (106)
Cancer (697)
Cardiovascular disease (74)
Career advice (489)
Cell therapy (130)
Clinical research (31298)
Collaboration (306)
COVID-19 (2150)
C-suite (63)
Data (840)
Diabetes (115)
Diagnostics (4745)
Drug pricing (85)
Earnings (33258)
Employer resources (70)
Events (71306)
Executive appointments (264)
FDA (11179)
Funding (295)
Gene therapy (93)
GLP-1 (338)
Government (4073)
Healthcare (14891)
Infectious disease (2233)
Inflammatory bowel disease (75)
IPO (7652)
Job creations (1420)
Job search strategy (447)
Layoffs (154)
Legal (3897)
Lung cancer (94)
Manufacturing (119)
Medical device (9267)
Medtech (9270)
Mergers & acquisitions (10489)
Metabolic disorders (309)
Neuroscience (1003)
NextGen Class of 2024 (4971)
Non-profit (3917)
Northern California (970)
Obesity (186)
Opinion (107)
People (32233)
Phase I (9945)
Phase II (12269)
Phase III (11158)
Pipeline (297)
Policy (59)
Postmarket research (1574)
Preclinical (3160)
Radiopharmaceuticals (147)
Rare diseases (173)
Real estate (2837)
Regulatory (13658)
Research institute (1904)
Southern California (768)
Startups (2078)
United States (9356)
Vaccines (455)
Weight loss (117)
Date
Last 7 days (366)
Last 30 days (1499)
Last 365 days (21738)
2024 (21637)
2023 (24284)
2022 (33706)
2021 (37156)
2020 (37594)
2019 (33272)
2018 (24889)
2017 (17736)
2016 (18890)
2015 (21471)
2014 (16091)
2013 (12756)
2012 (13484)
2011 (13934)
2010 (11945)
Location
Africa (510)
Arizona (95)
Asia (21175)
Australia (3798)
California (2083)
Canada (944)
China (177)
Colorado (113)
Connecticut (137)
Europe (47264)
Florida (325)
Georgia (112)
Illinois (264)
Indiana (199)
Japan (63)
Kansas (72)
Maine (59)
Maryland (434)
Massachusetts (1687)
Michigan (109)
Minnesota (157)
New Jersey (779)
New York (680)
North Carolina (510)
Northern California (970)
Ohio (94)
Pennsylvania (607)
South America (669)
Southern California (768)
Texas (284)
Utah (89)
Washington State (278)
391,800 Results for "bausch health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb
December 12, 2024
·
3 min read
Press Releases
Bausch Health Appoints New Chief Medical Officer and Head of R&D
December 3, 2024
·
3 min read
Bausch Health Announces 2024 Annual Meeting of Shareholder Results
Bausch Health Companies Inc. announced the results of its 2024 annual meeting of shareholders.
May 15, 2024
·
2 min read
Business
Bausch Health Announces First Quarter 2024 Results
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (“Bausch Health” or the “Company” or “we” or “our”) today announced its first quarter 2024 financial results and other key updates from the quarter.
May 2, 2024
·
41 min read
Press Releases
Bausch Health Announces Third Quarter 2024 Results
October 31, 2024
·
44 min read
Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences
Bausch Health Companies Inc., a global diversified pharmaceutical company enriching lives through a relentless drive to deliver better health outcomes, recently presented at two global healthcare conferences.
June 14, 2024
·
6 min read
Business
Bausch Health to Announce First-Quarter 2024 Results on May 2
Bausch Health Companies Inc. will release first-quarter 2024 financial results on Thursday, May 2, 2024. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business update.
April 11, 2024
·
1 min read
Policy
Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens
Bausch + Lomb Corporation, a leading global eye health company dedicated to helping people see better to live better, announced that Health Canada has approved the enVista® Envy™* full visual range intraocular lens.
May 28, 2024
·
4 min read
Press Releases
Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024
October 10, 2024
·
1 min read
Bausch Health Companies to Present at Cowen Annual Health Care Conference
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that members of company management will participate at the Cowen Annual Health Care Conference in Boston on March 5, 2024.
March 1, 2024
·
1 min read
1 of 39,180
Next
